Profound Medical Corp. Common Stock (PROF)
Stock · NASDAQ · Health Care
$6.02as of 10/16/2026
Price chart
Active signals
PROF Signal Track Record
How signals performed across all stocks →What PROF's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 46 | -1.0% | 48% | September 25, 2026 |
| Bollinger Band Breakout | 25 | -4.0% | 36% | October 8, 2026 |
| Bollinger Band Breakdown | 21 | +4.2% | 52% | September 10, 2026 |
| 200-Day Moving Average TouchActive now | 13 | -8.4% | 46% | August 24, 2026 |
| Any 20-session window (baseline) | -0.9% | 48% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PROF
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 162
- Website
- profoundmedical.com/
Fundamentals
- 1-day range
- $6.01$6.34
- Market cap
- $288.52M
- P/E (trailing)
- —
- P/E (forward)
- -10.36
- EPS (trailing)
- $-0.99
- Dividend yield
- —
- Beta
- 2.29
- Avg. volume
- 186.9K
- Dividend pay date
- October 16, 2019
How Profound Medical Corp. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 5, 2026 · via SEC EDGAR / Finnhub
Forecasts
5 analyst ratings
Profound Medical Corp. Common Stock Competitors
Chosen by industry and closest market cap.
- PROFProfound Medical Corp. Common Stock$6.01▼ 4.75%Market cap $288.52MP/E —$6.52$12.4
- DRTSWAlpha Tau Medical Ltd. Warrant$2.68▼ 10.37%Market cap $284.27MP/E —$0.2725$4.62
- TMCITreace Medical Concepts Inc. Common Stock$3.87▼ 6.07%Market cap $284.14MP/E —$1.17$7.08
- OSUROraSure Technologies Inc. Common Stock$3.61▼ 5.25%Market cap $275.39MP/E —$2.08$4.58
- ANIKAnika Therapeutics Inc. Common Stock$19.98▼ 3.43%Market cap $269.80MP/E —$8.67$22.88
- INFUInfuSystems Holdings Inc. Common Stock$13.4▼ 3.74%Market cap $236.42MP/E 31.71$7.29$13.85
- SENSSenseonics Holdings Inc. Common Stock$7.77▼ 5.59%Market cap $215.29MP/E —$4.79$10.64
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PROF Profound Medical Corp. Common Stock | $288.52M | — | $6.01 | ▼ 4.75% | $6.52$12.4 |
| DRTSW Alpha Tau Medical Ltd. Warrant | $284.27M | — | $2.68 | ▼ 10.37% | $0.2725$4.62 |
| TMCI Treace Medical Concepts Inc. Common Stock | $284.14M | — | $3.87 | ▼ 6.07% | $1.17$7.08 |
| OSUR OraSure Technologies Inc. Common Stock | $275.39M | — | $3.61 | ▼ 5.25% | $2.08$4.58 |
| ANIK Anika Therapeutics Inc. Common Stock | $269.80M | — | $19.98 | ▼ 3.43% | $8.67$22.88 |
| INFU InfuSystems Holdings Inc. Common Stock | $236.42M | 31.71 | $13.4 | ▼ 3.74% | $7.29$13.85 |
| SENS Senseonics Holdings Inc. Common Stock | $215.29M | — | $7.77 | ▼ 5.59% | $4.79$10.64 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Profound Medical and Telix Pharmaceuticals Partner to Advance Prostate Cancer Imaging and Treatment EducationYahoo · 10/9/2026
- Profound Medical Signs Agreement With Telix Pharmaceuticals To Educate Urologists, Radiologists, Nuclear Medicine Physicians, Prostate Cancer Centers Over Roles Of Telix’s Advanced Prostate-Specific Membrane Antigenbenzinga · 10/9/2026
- Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate CareYahoo · 10/9/2026
- Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?Yahoo · 10/9/2026
- Profound Medical: Q3 Revenue Beats Outlook (Rating Upgrade)SeekingAlpha · 10/9/2026
- Profound Medical Signs Agreement With Telix Pharmaceuticals To Educate Urologists, Radiologists, Nuclear Medicine Physicians, Prostate Cancer Centers Over Roles Of Telix’s Advanced Prostate-Specific Membrane AntigenBenzinga · 10/9/2026
- Top stock movements in today's session.ChartMill · 10/8/2026
- Let's take a look at the stocks that are in motion in today's session.ChartMill · 10/8/2026
- Thursday's pre-market session: top gainers and losersChartMill · 10/8/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 16.43M
- Total value held
- $102.78M
- Institutional holders
- 58
- Unknown2.34M
- Unknown1.94M
- Unknown1.12M
- Unknown1.11M
- Unknown962.2K
- Unknown953.2K
- Unknown828.1K
- Unknown818.0K
- Unknown745.2K
- Unknown575.0K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Profound Medical Featured in AI Healthcare Stock List
Profound Medical Corp. was included in a recent list of three Canadian AI healthcare stocks with market caps up to $296 million. This mention highlights the company's position within the emerging AI health sector. The stock is currently trading near its 52-week low, reflecting a significant drop from its recent high.
Profound Medical Featured in AI Healthcare Stock List. Profound Medical Corp. was included in a recent list of three Canadian AI healthcare stocks with market caps up to $296 million. This mention highlights the company's position within the emerging AI health sector. The stock is currently trading near its 52-week low, reflecting a significant drop from its recent high.